<SEC-DOCUMENT>0001171843-25-000441.txt : 20250127
<SEC-HEADER>0001171843-25-000441.hdr.sgml : 20250127
<ACCEPTANCE-DATETIME>20250127143907
ACCESSION NUMBER:		0001171843-25-000441
CONFORMED SUBMISSION TYPE:	SCHEDULE 13G/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20250127

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			XBiotech Inc.
		CENTRAL INDEX KEY:			0001626878
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			A1
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-88810
		FILM NUMBER:		25558016

	BUSINESS ADDRESS:	
		STREET 1:		5217 WINNEBAGO LANE
		CITY:			AUSTIN
		STATE:			TX
		ZIP:			78744
		BUSINESS PHONE:		512-386-2900

	MAIL ADDRESS:	
		STREET 1:		5217 WINNEBAGO LANE
		CITY:			AUSTIN
		STATE:			TX
		ZIP:			78744

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MCKENZIE W  THORPE
		CENTRAL INDEX KEY:			0001211462
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G/A

	MAIL ADDRESS:	
		STREET 1:		735 BROAD ST
		STREET 2:		STE 1105
		CITY:			CHATTANOOGA
		STATE:			TN
		ZIP:			37402
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13G/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>SCHEDULE 13G/A</submissionType>
    <previousAccessionNumber>0001171843-16-007905</previousAccessionNumber>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: MCKENZIE W %A0THORPE -->
          <cik>0001211462</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <amendmentNo>8</amendmentNo>
      <securitiesClassTitle>Common Shares, no par value</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>12/31/2024</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0001626878</issuerCik>
        <issuerName>XBIOTECH, INC.</issuerName>
        <issuerCusip>98400H102</issuerCusip>
        <issuerPrincipalExecutiveOfficeAddress>
          <com:street1>5217 WINNEBAGO LANE</com:street1>
          <com:city>AUSTIN</com:city>
          <com:stateOrCountry>TX</com:stateOrCountry>
          <com:zipCode>78744</com:zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>
      <designateRulesPursuantThisScheduleFiled>
        <designateRulePursuantThisScheduleFiled>Rule 13d-1(d)</designateRulePursuantThisScheduleFiled>
      </designateRulesPursuantThisScheduleFiled>
    </coverPageHeader>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>W. Thorpe McKenzie</reportingPersonName>
      <citizenshipOrOrganization>X1</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>2881221.00</soleVotingPower>
        <sharedVotingPower>106288.00</sharedVotingPower>
        <soleDispositivePower>2881221.00</soleDispositivePower>
        <sharedDispositivePower>106288.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>2987509.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>9.71</classPercent>
      <typeOfReportingPerson>IN</typeOfReportingPerson>
      <comments>(1) These figures include shares of common stock underlying stock options held by the Reporting Person, including options that are immediately exercisable within 60 days of December 31, 2024.

(2) Includes 66,748 shares held by the McKenzie Foundation, 31,864 shares held by Mr. McKenzie's spouse and 7,676 shares held in a Trust for Mr. McKenzie's stepchildren.

(3) The Reporting Person's spouse owns, controls and holds sole dispositive power to 31,864 shares for which the Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein. The Reporting Person's Foundation owns, controls and holds sole dispositive power to 66,748 shares for which the Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein. The Reporting Person's stepchildren owns, controls and holds sole dispositive power to 7,676 shares for which the Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.

(4) The percentage is calculated based upon 30,487,731 shares outstanding as of December 31, 2024.</comments>
    </coverPageHeaderReportingPersonDetails>
    <items>
      <item1>
        <issuerName>XBIOTECH, INC.</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>5217 Winnebago Ln, Austin, TX 78744</issuerPrincipalExecutiveOfficeAddress>
      </item1>
      <item2>
        <filingPersonName>W. Thorpe McKenzie</filingPersonName>
        <principalBusinessOfficeOrResidenceAddress>832 Georgia Avenue, Suite 1100
Chattanooga, TN 37402</principalBusinessOfficeOrResidenceAddress>
        <citizenship>USA</citizenship>
      </item2>
      <item3>
        <notApplicableFlag>Y</notApplicableFlag>
      </item3>
      <item4>
        <amountBeneficiallyOwned>2,987,509 shares</amountBeneficiallyOwned>
        <classPercent>9.71%</classPercent>
        <numberOfSharesPersonHas>
          <solePowerOrDirectToVote>2,881,221 shares</solePowerOrDirectToVote>
          <sharedPowerOrDirectToVote>106,288</sharedPowerOrDirectToVote>
          <solePowerOrDirectToDispose>2,881,221 shares</solePowerOrDirectToDispose>
          <sharedPowerOrDirectToDispose>106,288</sharedPowerOrDirectToDispose>
        </numberOfSharesPersonHas>
      </item4>
      <item5>
        <notApplicableFlag>Y</notApplicableFlag>
      </item5>
      <item6>
        <notApplicableFlag>Y</notApplicableFlag>
      </item6>
      <item7>
        <notApplicableFlag>Y</notApplicableFlag>
      </item7>
      <item8>
        <notApplicableFlag>Y</notApplicableFlag>
      </item8>
      <item9>
        <notApplicableFlag>Y</notApplicableFlag>
      </item9>
      <item10>
        <notApplicableFlag>Y</notApplicableFlag>
      </item10>
    </items>
    <signatureInformation>
      <reportingPersonName>W. Thorpe McKenzie</reportingPersonName>
      <signatureDetails>
        <signature>/s/ W. Thorpe McKenzie</signature>
        <title>W. Thorpe McKenzie</title>
        <date>01/27/2025</date>
      </signatureDetails>
    </signatureInformation>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
